Skip to main content
logo
NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
12.33
+0.30 (2.49%)
At close: Aug 29, 2025, 4:00 PM
12.34
+0.01 (0.08%)
After-hours: Aug 29, 2025, 7:11 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Tumor Treating Fields
605.22M
Log In
Log In
Log In
Log In
Upgrade
Tumor Treating Fields Growth
18.82%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
391.80M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
12.03%
Log In
Log In
Log In
Log In
Upgrade
Germany
65.26M
Log In
Log In
Log In
Log In
Upgrade
Germany Growth
8.39%
Log In
Log In
Log In
Log In
Upgrade
France
55.73M
Log In
Log In
Log In
Log In
Upgrade
Japan
32.57M
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
2.85%
Log In
Log In
Log In
Log In
Upgrade
Greater China
17.39M
Log In
Log In
Log In
Log In
Upgrade
Greater China Growth
-25.14%
Log In
Log In
Log In
Log In
Upgrade
Other
42.47M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-4.54%
Log In
Log In
Log In
Log In
Upgrade
Other EMEA
-
Log In
Log In
Log In
Log In
Upgrade
Other EMEA Growth
-
Log In
Log In
Log In
Log In
Upgrade